|
28/11/2018 |
Colilen IBS- Irritable Bowel Syndrome- adults-Phase III |
ABOCA |
Registered outdated |
|
30/06/2021 |
Anti SARS-CoV-2 gammaglobulin |
AICA |
Registered outdated |
|
2012-04-02 |
Sublingual immunotherapy with VALERGEN-Asthma-Children-Phase II |
BIOCEN |
Registered |
|
2012-04-13 |
Combined Subcutaneous immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II |
BIOCEN |
Registered |
|
2013-01-04 |
Subcutaneous immunotherapy with PROLINEM -Asthma- Adults-Fase I |
BIOCEN |
Registered |
|
2010-12-07 |
Efficacy of VALERGENT-BT subcutaneous vaccine in asthmatic adults |
BIOCEN |
Registered |
|
2010-12-07 |
Efficacy of VALERGEN-DP subcutaneous vaccine in asthmatic adults |
BIOCEN |
Registered |
|
2010-12-07 |
Efficacy of VALERGEN-DS subcutaneous vaccine in asthmatic adults. |
BIOCEN |
Registered |
|
2010-12-08 |
Efficacy of VALERGEN-BT sublingual vaccine in asthmatic adults. |
BIOCEN |
Registered |
|
2010-12-08 |
Efficacy of VALERGEN-DS sublingual vaccine in asthmatic adults |
BIOCEN |
Registered |
|
2010-12-09 |
Evidence of the clinical efficacy of VALERGEN-DS vaccine in asthmatics. |
BIOCEN |
Registered |
|
2010-12-09 |
Evidence of the clinical efficacy of VALERGEN-BT vaccine in asthmatics |
BIOCEN |
Registered |
|
2010-12-09 |
Efficacy of VALERGEN-DP sublingual vaccine in asthmatic adults. |
BIOCEN |
Registered |
|
2010-12-09 |
Evidence of the clinical efficacy of VALERGEN-DP vaccine in asthmatics |
BIOCEN |
Registered |
|
05/05/2020 |
Biomodulina T - IM- covid-19 - older adultos - Phase IV clinical trial |
BIOCEN |
Registered |
|
27/01/2017 |
Pharmacovigilance-VALERGEN-Asthma |
BIOCEN |
Registered |
|
03/08/2020 |
Biomodulina T in pediatric septic shock. Exploratory study |
BIOCEN |
Registered |
|
14/06/2018 |
Subcutaneous immunotherapy with PROLINEM-DS-Asthma- Adults-Fase II |
BIOCEN |
Registered outdated |
|
28/05/2020 |
Exploratory study of BMT EV to stimulate immune response in patients with CKD-5 on iterated hemodialysis |
BIOCEN |
Registered |
|
15/08/2018 |
Evaluation of Biomodulin T® in patients with HIV/AIDS. Phase II/III. |
BIOCEN |
Registered outdated |
